198 related articles for article (PubMed ID: 15299241)
1. Time-controlled pulse-drug release from dry-coated wax matrix tablets for colon drug delivery.
Peerapattana J; Otsuka K; Otsuka M
Biomed Mater Eng; 2004; 14(3):293-301. PubMed ID: 15299241
[TBL] [Abstract][Full Text] [Related]
2. Statistical optimization of indomethacin pellets coated with pH-dependent methacrylic polymers for possible colonic drug delivery.
Akhgari A; Afrasiabi Garekani H; Sadeghi F; Azimaie M
Int J Pharm; 2005 Nov; 305(1-2):22-30. PubMed ID: 16236475
[TBL] [Abstract][Full Text] [Related]
3. The release mechanism of an oral controlled-release delivery system for indomethacin.
Talukdar MM; Rombaut P; Kinget R
Pharm Dev Technol; 1998 Feb; 3(1):1-6. PubMed ID: 9532594
[TBL] [Abstract][Full Text] [Related]
4. A novel double-coating approach for improved pH-triggered delivery to the ileo-colonic region of the gastrointestinal tract.
Liu F; Moreno P; Basit AW
Eur J Pharm Biopharm; 2010 Feb; 74(2):311-5. PubMed ID: 19932177
[TBL] [Abstract][Full Text] [Related]
5. Sustained release phenylpropanolamine hydrochloride from ATO 888 matrix.
Perez MA; Ghaly ES; Marti A
P R Health Sci J; 1993 Dec; 12(4):263-7. PubMed ID: 8140204
[TBL] [Abstract][Full Text] [Related]
6. Controlled release of theophylline from inert matrices: effect of channeling material on release rate.
Ghaly ES; Malavé MI; Rivera WJ; Martí A
P R Health Sci J; 1993 Dec; 12(4):255-8. PubMed ID: 8140202
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of hydrophobic materials as matrices for controlled-release drug delivery.
Quadir MA; Rahman MS; Karim MZ; Akter S; Awkat MT; Reza MS
Pak J Pharm Sci; 2003 Jul; 16(2):17-28. PubMed ID: 16414573
[TBL] [Abstract][Full Text] [Related]
8. Different HPMC viscosity grades as coating agents for an oral time and/or site-controlled delivery system: a study on process parameters and in vitro performances.
Sangalli ME; Maroni A; Foppoli A; Zema L; Giordano F; Gazzaniga A
Eur J Pharm Sci; 2004 Aug; 22(5):469-76. PubMed ID: 15265517
[TBL] [Abstract][Full Text] [Related]
9. Design and in vitro evaluation of formulations with pH and transit time controlled sigmoidal release profile for colon-specific delivery.
Asghar LF; Azeemuddin M; Jain V; Chandran S
Drug Deliv; 2009 May; 16(4):205-13. PubMed ID: 19514981
[TBL] [Abstract][Full Text] [Related]
10. The effect of type and concentration of vehicles on the dissolution rate of a poorly soluble drug (indomethacin) from liquisolid compacts.
Nokhodchi A; Javadzadeh Y; Siahi-Shadbad MR; Barzegar-Jalali M
J Pharm Pharm Sci; 2005 Jan; 8(1):18-25. PubMed ID: 15946594
[TBL] [Abstract][Full Text] [Related]
11. Non-coated multiparticulate matrix systems for colon targeting.
Krenzlin S; Siepmann F; Wils D; Guerin-Deremaux L; Flament MP; Siepmann J
Drug Dev Ind Pharm; 2011 Oct; 37(10):1150-9. PubMed ID: 21417601
[TBL] [Abstract][Full Text] [Related]
12. Design and in vitro evaluation of formulations with pH and transit time controlled sigmoidal release profile for colon-specific delivery.
Ali Asghar LF; Azeemuddin M; Jain V; Chandran S
Drug Deliv; 2009 Aug; 16(6):295-303. PubMed ID: 19606943
[TBL] [Abstract][Full Text] [Related]
13. Colon-specific delivery tablets of sodium 4-aminosalicylic acid.
Li Y; Li HJ; Yang GR; Gu WP; Ma YK; Zhang MH; Sun J; Sun SJ
Yao Xue Xue Bao; 2006 Oct; 41(10):927-32. PubMed ID: 17184108
[TBL] [Abstract][Full Text] [Related]
14. Combination of time-dependent and pH-dependent polymethacrylates as a single coating formulation for colonic delivery of indomethacin pellets.
Akhgari A; Sadeghi F; Garekani HA
Int J Pharm; 2006 Aug; 320(1-2):137-42. PubMed ID: 16782290
[TBL] [Abstract][Full Text] [Related]
15. Modulation of drug release kinetics of shellac-based matrix tablets by in-situ polymerization through annealing process.
Limmatvapirat S; Limmatvapirat C; Puttipipatkhachorn S; Nunthanid J; Luangtana-anan M; Sriamornsak P
Eur J Pharm Biopharm; 2008 Aug; 69(3):1004-13. PubMed ID: 18362064
[TBL] [Abstract][Full Text] [Related]
16. In-vitro evaluation of khaya and albizia gums as compression coatings for drug targeting to the colon.
Odeku OA; Fell JT
J Pharm Pharmacol; 2005 Feb; 57(2):163-8. PubMed ID: 15720778
[TBL] [Abstract][Full Text] [Related]
17. Matrices for site-specific controlled-delivery of 5-fluorouracil to descending colon.
Zambito Y; Baggiani A; Carelli V; Serafini MF; Di Colo G
J Control Release; 2005 Feb; 102(3):669-77. PubMed ID: 15681088
[TBL] [Abstract][Full Text] [Related]
18. A comparative in vitro assessment of the drug release performance of pH-responsive polymers for ileo-colonic delivery.
Ibekwe VC; Fadda HM; Parsons GE; Basit AW
Int J Pharm; 2006 Feb; 308(1-2):52-60. PubMed ID: 16356670
[TBL] [Abstract][Full Text] [Related]
19. Guar gum as a carrier for colon specific delivery; influence of metronidazole and tinidazole on in vitro release of albendazole from guar gum matrix tablets.
Krishnaiah YS; Seetha Devi A; Nageswara Rao L; Bhaskar Reddy PR; Karthikeyan RS; Satyanarayana V
J Pharm Pharm Sci; 2001; 4(3):235-43. PubMed ID: 11737989
[TBL] [Abstract][Full Text] [Related]
20. Coating polymers for colon specific drug delivery: a comparative in vitro evaluation.
Sinha VR; Kumria R
Acta Pharm; 2003 Mar; 53(1):41-7. PubMed ID: 14769251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
